20104 results for «»
20104 results
Challenging scenarios in NSTEMI
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex and challenging scenarios encountered in the management of NSTEMI patients. Participants will delve into discussions on topics such as coronary artery aneurysm, restenosis of coronary ostial stents, right-sided chest pain, subsequent occlusions of the left anterior...
The value of IVUS during CTO PCI
16 May 2024 – From EuroPCR 2024
This session explores the role of IVUS imaging in the management of chronic total occlusions (CTOs) during PCI procedures. Participants will learn how IVUS can help in navigating the true lumen, utilizing retrograde plaque/flap lift-and-shift techniques, managing false lumen entry, and addressing other challenging scenarios in...
Challenging LAA occlusion cases
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex and challenging scenarios in left atrial appendage (LAA) occlusion procedures. Participants will learn about techniques for rescuing a migrating LAA occluder, managing incomplete surgical LAA ligation, and utilizing specialized techniques like the "kissing" approach for LAA...
Innovative approaches to rare PCI complications in NSTEMI
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex PCI scenarios in NSTEMI patients. Participants will learn about rare complications following coronary angioplasty, strategies for identifying the correct culprit lesion, techniques for managing pericardial effusion, and other challenging situations encountered during complex PCI in NSTEMI....
Complications in CTO: is there a bailout?
16 May 2024 – From EuroPCR 2024
Watch this session on CTO complications and explore unique challenges and solutions, including a retrograde CTO technique with a twist, an unexpected outcome in a right coronary artery case, and an atypical perforation caused by an unexpected equipment issue. You’ll also see how a guide wire...
Feedback from Innovator's Exchange Hub
13 May 2024 – From EuroPCR 2024
Vulnerable plaque identification and treatment
16 May 2024 – From EuroPCR 2024
This session focuses on the role of non-invasive and intra-coronary imaging in the identification and management of vulnerable plaque. Participants will explore the use of CCTA and intracoronary imaging techniques, such as IVUS, to diagnose vulnerable atherosclerosis. The session also evaluates the evidence supporting conservative or...
Innovations in heart failure: moving the heart forward
13 May 2024 – From EuroPCR 2024
Management of LAA closure complications
16 May 2024 – From EuroPCR 2024
This session explores the various complications that can arise during left atrial appendage (LAA) closure procedures, including pericardial effusion, device embolisation, and procedural strokes. Learn how to identify risk factors, prevent these complications, and effectively manage them through case-based discussions and expert guidance.
Is this patient a good candidate for Left Atrial Appendage Closure? An interactive rapid-fire discussion
16 May 2024 – From EuroPCR 2024
This interactive session focuses on selecting good candidates for left atrial appendage (LAA) closure procedures. It covers the key clinical elements driving the indication for LAA closure and the technical elements that make a case complex. Through a series of case presentations and discussions, the session...
EuroPCR 2024 – Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
EuroPCR 2024 – Short-term data from NOTION-2: TAVR versus SAVI for younger patients with aortic stenosis
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice....
EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
Challenges and complications in STEMI: resuscitated cardiac arrest, left ventricular free wall rupture & more!
16 May 2024 – From EuroPCR 2024
This session presents a series of challenging and complex STEMI cases, highlighting the various complications that can arise during primary PCI. Attendees will witness real-life scenarios, including resuscitated cardiac arrest, the use of rotational atherectomy, left ventricular free wall rupture, and more. Through interactive discussions, the...
EuroPCR 2024: Primary outcomes from PINNACLE I clinical trial establish safety and effectiveness of Elixir Medical’s Hertz Contact Intravascular Lithotripsy System for calcium fragmentation in moderate to severe calcified coronary artery lesions
16 May 2024
MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.
15 May 2024
PCI of calcified lesions
16 May 2024 – From EuroPCR 2024
This session delves into the treatment of calcified lesions, providing a comprehensive overview of contemporary tools and techniques for optimal plaque modification. Attendees will learn through a series of case presentations, where experts dissect challenging cases involving severe coronary calcification, including in the left main trunk....
The Jon DeHaan Foundation rewards another innovative idea!
15 May 2024
The competition for the Jon DeHaan Foundation Award was tough at PCR lnnovators Day 2024, but the A-FLUX Reducer System was crowned the winner.
REC-CAGEFREE II, NOTION-2, LANDMARK: Three major late-breaking trials presented at EuroPCR 2024
15 May 2024
The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice.
Vascular robotics: Robocath unveils survey findings on users’ current expectations and future developments
15 May 2024